A Grand View Research report found the small syringes market is expected to reach $10.2 billion by 2024.
Here are six highlights:
1. The higher prevalence of needle stick injuries and unhygienic injection practices leading to diseases is fueling market growth.
2. A rising patient population is also spurring market expansion.
3. The auto-disposable syringes segment had revenue surpassing $3 billion in 2015.
4. A rise in disease burden, higher population levels and increasing vaccination demand are key factors driving Asia Pacific growth, with the report claiming Asia Pacific is the "most lucrative market."
5. Last year, North America had the largest share due to more patient awareness and demand for sophisticated drug delivery techniques.
6. Market vendors include Medtronic, Terumo Medical, Braun Melsungen, Unilife, Becton, Dickinson and Co., Revolutions Medical, Baxter, Retractable Technologies and Smiths Group.
More articles on quality & infection control:
The rules of infection control have changed: AAAHC surveyor highlights 3 compliance issues & APIC's role in ASC compliance
Medicaid & commercial payers forgo restrictions on costly hepatitis C medications: 7 notes
Staph infection poses greatest risk among siblings: 3 observations
